Movatterモバイル変換


[0]ホーム

URL:


Vis innførsel 
JavaScript is disabled for your browser. Some features of this site may not work without it.

Systems Medicine: From Modeling Systems Perturbations to Predicting Drug Synergies

Sammendrag
Computational approaches to systems biology and systems medicine enable the study of

systems properties that emerge from integrating knowledge about complex interactions, such

as in the study of cancer cell phenotypes from cellular signaling networks.

This doctoral thesis explores approaches to assemble knowledge of molecular interactions

into a comprehensive representation of cellular responses to perturbations. Cellular responses

to the gut hormones gastrin and cholecystokinin are analyzed from the perspective of

receptor-mediated signaling, demonstrating how current state of the art knowledge can be

improved by exploiting a data-driven approach to extending signaling networks. In order to

enable reasoning over signaling networks, these are coupled with a logical mathematical

formalism, followed by simulation-enabled studies of the response of cell fate networks to

pairwise signaling perturbations. A manually curated and parameterized model of the AGS

gastric adenocarcinoma cell line correctly predicted 20 of 21 drug combination responses as

validated by AGS cell growth experiments. The model correctly identified four synergistic

drug interactions. Of these four, two drug synergies described already well-known

combination responses that are explored in on-going clinical trials. One of the two novel drug

synergies was further validated in in vivo experiments.

Based the insights gained from manually curating a logical model the thesis presents

foundations on how to automatically obtain predictive models for a given drug panel and a

given experimental system. A proof-of-concept approach enabling the automated signaling

network assembly and cellular calibration through parameterization of logical equations is

presented. This approach can form the basis for a computational pipeline to efficiently

generate a well functioning predictive companion model to a given cancer model system.

The computational approaches presented here depend on extensive validation in large cancer

cell line drug synergy screening experiments. In order to enable efficient identification of

experimental synergistic effects the user-friendly and open-source tool CImbinator is

presented to analyze and visualize information in such datasets (available at

http://cimbinator.bioinfo.cnio.es/).
Utgiver
NTNU
Serie
Doctoral thesis at NTNU;2016:55

Bla i

Min side

Statistikk


[8]ページ先頭

©2009-2025 Movatter.jp